Clinical Trial Update: Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary Hypertension [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating repurposing a histamine antagonist for pulmonary arterial hypertension and associated right heart failure; results have been p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Right Heart Failure

Drugs mentioned

• Histamine antagonist (unspecified)

Snippet

Sponsor: University of Washington | Conditions: Pulmonary Arterial Hypertension, Right Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2024-08-09